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ABSTRACT 
Evidence suggests that opiate receptor development plays a role in mor­
phine-induced analgesia. From birth to about 15 days of age in rats, there 
is a concomitant increase in number of opiate receptors and morphine-in­
duced analgesic effect with virtually no change in blood-brain barrier 
maturation. The present two experiments examined possible age-related 
changes in tolerance to morphine-induced analgesic, hypoactive, and hyper­
thermic effects during this period. 
In Experiment 1, rats were administered either morphine (1 mg/kg), sal-
line, or no treatment at one day of age. At 26 days of age, one half of 
the animals from each infant treatment group received morphine (5 mg/kg) 
and the other half received saline. All animals were then assessed for 
pain responsivity, activity and body temperature. This injection-test pro­
cedure was repeated at 27 and 28 days of age. At 29 days of age, all an­
imals received morphine and were similarly tested. Rats treated with mor­
phine one day after birth subsequently displayed tolerance to morphine-in-
duced analgesic and hypoactive effects, but not to hyperthermic effects. 
Infant slaine-treated animals displayed less activity and higher body tem­
peratures than infant untreated animals. 
In Experiment 2, rats were administered either morphine (1 mg/kg) or 
saline at 1, 5, 9, or 13 days of age. At 26 days of age, one half of each 
infant treatment group received morphine (5 mg/kg) and the other half re­
ceived saline. Injections and tests for pain responsivity, activity, and 
body temperature were similar to those of Experiment 1. Animals treated 
with morphine at 1 but not at 5, 9, or 13 days of age displayed tolerance 
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to morphine-induced analgesic and hypoactive effects. Animals treated with 
saline early in infancy displayed less pain responsivity and activity than 
animals treated with saline late in infancy. 
These results indicate that single-dose tolerance to 1 mg/kg morphine 
in infants is age-dependent. Age-dependent changes in susceptibility to 
single-dose morphine tolerance may reflect a change in either blood-brain 
barrier or opiate receptor development. Furthermore, these results indi­
cate that saline injection in infancy may produce stress-related changes 
in later pain responsivity, activity, and body temperature. 
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INTRODUCTION 
A single systemic injection of morphine (5-15 mg/kg) can produce 
various transient behavioral and physiological effects in rats. These 
effects include: analgesia (Bonnet and Peterson, 1975; D'Amour and Smith, 
1941; Evans, 1961; Johannesson and Woods, 1964; Saunders, Paolino, Bousquet, 
and Miya, 1974), hypoactivity (Collins, 1965; Kuschinsky and Hornykiewicz, 
1974) and hyperthermia (Cox, Ary, Chesarek and Lomax, 1976; Martin, 
Pryzbylik, and Spector, 1977; Siegel, 1978). Each of these effects dimin­
ishes with repeated morphine injections at a constant dose and this dimin­
ished effect is termed tolerance. Although tolerance to the analgesic 
effect can be obtained following a single morphine injection (Cochin and 
Kornetsky, 1964; Kometsky and Bain, 1968) , tolerance to the hyperthermic 
effect requires a substantially greater number of injections (Fernandas, 
Kluwe and Coper, 1977). These results demonstrate that the rate of toler­
ance development depends on which morphine effect is assessed. 
Recent evidence indicates that some morphine effects depend on the 
developmental age of the animal. In particular, two major developmental 
events are important determinants of morphine effects across the life-span. 
First, the blood-brain barrier (BBB) to morphine in rats is virtually non­
existent before about 16-20 days of age. Although fetal rats are partially 
protected from morphine by a placental barrier (Johannesson, Steele, and 
Becker, 1972), neonates are extremely susceptible to morphine effects. 
This morphine susceptibility diminishes at about 16-20 days of age, as the 
BBB to morphine begins to develop, and susceptibility rapidly becomes adult­
like by about 26-32 days of age as BBB development stabilizes (Johannesson 
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and Becker, 1973; Johannesson, Steele, and Becker, 1972; Kupferberg and 
Way, 1963). 
Development of brain opiate receptors is a second major determinant of 
some morphine effects- Studies investigating stereospecific binding of the 
opiate antagonists naloxone and naltrexone in rats indicate that opiate 
receptors are first evident about 15 days into gestation, and that the 
number of receptors progressively increases throughout the remainder of 
gestation and postpartum maturation (Clendeninn, Petraitis, and Simon, 1976; 
Coyle and Pert, 1976). These experiments indicate an approximately 15-
fold increase in the number of opiate receptors from birth to 60 days of 
age. Although increased opiate receptor development might be expected to 
produce a concomitant increase in morphine effects, this is not the case 
for all morphine effects. The lethal dose (LD^Q) of morphine, for example, 
is more directly related to BBB development than to opiate receptor devel­
opment. Kupferberg and Way (1963) injected rats intraperitoneally with 
morphine at either 1, 2, 4, 8, 12, 16, 24, or 32 days of age and found that 
LD^Q was 45 mg/kg in 1-16 day-olds, 125 mg/kg in 24 day-olds and 220 mg/ 
kg in 32 day-olds. This ontogenetic change in was inversely corre­
lated with brain permeability to morphine in blood. Since remained 
essentially constant from 1 to 16 days of age despite an increasing number 
of opiate receptors during this period, it is unlikely that morphine le­
thality is directly related to opiate receptor development. 
In contrast to morphine lethality, morphine-induced analgesic effects 
are thought to be more directly related to opiate receptor development, in 
part because morphine-induced analgesia is antagonized by naloxone, the 
5 
"pure" opiate antagonist which has greater affinity for the opiate receptor 
than morphine (Terenius, 1974) and also because morphine produces analgesia 
when microinjected into high density but not low density opiate receptor 
brain sites (Mayer and Murphin, 1976; Yaksh, Yeung and Rudy, 1975), Thus, 
morphine-induced analgesic effects might be expected to change as a function 
of the developmental increase in number of opiate receptors that occurs 
prior to BBB development. Consistent with this possibility, Auguy-Valette 
and co-workers (1978) tested rats at either 5, 10, 15, 20, 25, 30, 45, 60, 
or 120 days of age and observed an age-related biphasic change in morphine-
induced analgesic effect. The first phase (5-15 days) was characterized by 
an incremental sensitivity to morphine-induced analgesia that was paralleled 
by an increase in number of opiate receptors. The second phase (15-30 days) 
was characterized by a decremental sensitivity to morphine-induced analgesia 
that was paralleled by a decrease in brain permeability to the drug. These 
observations indicate that both opiate receptor and BBB development influr 
ence morphine-induced analgesic effects, although their influence is evident 
at different stages of infancy. 
Since acute morphine-induced analgesic effects are directly related to 
the number of opiate receptors prior to BBB development, chronic morphine-
induced analgesic effects involved in tolerance may also be related to 
opiate receptor development during this same period of infancy. Several 
studies have demonstrated that morphine administration in infancy produces 
reliable and long-lasting tolerance (Sonderegger, Bromley and Zimmermann, 
1977; Sonderegger and Zimmermann, 1976; Sonderegger and Zimmermann, 1978; 
Zimmermann, Branch, Newman Taylor, Young and Pang, 1974). In these in-
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stances, however, treatment consisted of relatively long-term morphine 
exposure (either pellet implantation or daily injections for one week or 
longer) and thus the potential relationship between opiate receptor devel­
opment and tolerance was not evaluated. Moreover, such long-term morphine 
exposure in infancy may produce increased mortality, decreased body weight, 
and delayed eye-opening onset (Zimmermann, Sonderegger, and Bromley, 1977). 
These profound physiological effects, which reflect retarded development, 
may be minimized by short-term rather than long-term morphine exposure 
at low dosage. Short-term, low-dose morphine exposure should also permit 
evaluation of the potential relationship between opiate receptor develop­
ment and tolerance. 
Some evidence suggests that early short-term exposure to a low dose 
of morphine may not lead to tolerance. Rats exposed to morphine on either 
the day before birth (Johannesson, Steele, and Becker, 1972) or the day 
after birth (Huidobro and Huidobro, 1973) display increased morphine-in-
duced analgesic effects (hyperanalgesia) when tested at a later age. These 
observations contrast with reports of tolerance following single-dose mor­
phine in adults (Cochin and Kornetsky, 1964; Kornetsky and Bain, 1968) and 
with reports of tolerance following long-term morphine exposure in infants 
(Sonderegger, Bromley, and Zimmermann, 1977; Sonderegger and Zimmermann, 
1976; Sonderegger and Zimmermann, 1978; Zimmermann, Branch, Newman Taylor, 
Young, and Pang, 1974). These contrasting observations suggest the inter­
esting possibility that short-term morphine exposure during early periods 
of opiate receptor development may induce increased sensitivity to sub­
sequent morphine treatment, and that short-term morphine exposure during 
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later periods of opiate receptor development may induce decreased sensi­
tivity to subsequent morphine treatment. The research reported here ex­
amined that possibility. 
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EXPERIMENT 1 
The purpose of this experiment was to determine if the observation 
of single-dose morphine hyperanalgesia reported by Huidobro and Huidobro 
(1973) could be replicated. Huidobro and Huidobro (1973) used two main 
treatment groups to demonstrate this effect. One group was subcutaneously 
injected with 1 mg/kg morphine at one day of age and the second group was 
untreated. At 16 days of age, each animal from both groups was subcuta-
neously injected with 1 mg/kg morphine and subsequently assessed for pain 
responsivity with a standard hot plate procedure, i.e., latency to perform 
a paw-lick response to a noxious thermal stimulus was measured. Animals 
given morphine at one day of age and tested at 16 days of age displayed 
greater morphine analgesia (hyperanalgesia) than untreated animals. How­
ever, since these two groups were not given similar handling-injection 
treatment at one day of age, it is not possible to conclude that the hyper-
analgesic effect reflects morphine exposure per se. Treatment of neonates 
which involves separation from the lactating mother may produce systematic 
behavioral and physiological changes in maternal care (Barnett and Burn, 
1967; Bell, Nitschke, Bell, and Zachman, 1974; Smotherman, Wiener, Mendoza, 
and Levine, 1977). These stress-related effects can influence pain res-
sponsivity independently of morphine by affecting pituitary-adrenal activ­
ity which can influence pain responsivity (Bodnar, Glusman, Spiaggia, Brutus, 
and Kelly, 1978). 
The present experiment examined the effects of early morphine and 
saline injection relative to no injection on subsequent morphine-induced 
changes in pain responsivity, activity, and body temperature. Tests of 
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these early treatments were given at 26 days of age rather than at the 16 
day age used by Huidobro and Huidobro (1973) since preliminary data from 
this laboratory indicated that paw-lick responses on a hot plate surface 
were extremely variable in 16-day-old animals. 
Method 
Animals. Nine multiparous pregnant Long-Evans hooded rats (Blue 
Spruce Farms, New York) arrived in our laboratory before parturition. 
They were individually caged in standard stainless steel maternity cages 
(43 X 26 X 18 cm) and maintained in a temperature and humidity controlled 
room under a 12 hour light-dark cycle with water and Teklad pellets con­
tinuously available. Maternity cages were inspected twice daily during 
the light hours, and the day on which a litter was first observed was 
designated as the day of parturition (Day 0). 
Apparatus. The hot plate apparatus consisted of a slide warming tray 
(Chicago Surgical & Electrical Co., 26020) with its temperature control 
dial set to remain constantly on at the highest temperature. Temperature 
was controlled and maintained at a relatively constant 52° C by a Variac 
(Standard Electrical Co., 300 BU). A 30 X 15 X 35 cm clear plastic chamber 
with a hinged top and open bottom was placed on the hot plate surface. The 
chamber was covered with brown adhesive paper except for the top and a 
30 X 7 cm window along the bottom of the front wall through which animals 
could be observed. The hot plate apparatus was placed in a 100 X 30 X90 cm 
wooden wall cabinet with the doors and shelves removed. A 15 W white light 
was mounted on the back wall of the cabinet interior and illuminated the 
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hot plate apparatus. Response latencies were recorded to the nearest 0.1 
sec by a hand-operated electronic timer (Hunter, 120A). The activity 
apparatus consisted of a 30 X 15 X 35 cm brown adhesive-paper covered 
chamber with a hinged top and hardware cloth floor. Four photocell sensors 
and light sources were arranged to divide this chamber interior into nine 
approximately equal rectangular sections 3 cm above the floor. Solid state 
equipment (Massey Dickinson) transduced and recorded photobearn interruptions. 
A reinforced thermistor bead (Fenwal Electronics, FA41J1) and ohmmeter 
(Hewlett-Packard, 3476A) were used to assess rectal temperature. All appa­
ratus was located in a room adjacent to where the animals were housed. 
Procedure. On the day after parturition (Day 1), pups in each litter 
were sexed and the litters culled to 10 pups (5 male and 5 female) whenever 
possible. After sexing and culling, which took about five minutes, all 
pups from six randomly chosen litters were weighed to the nearest 0.1 g and 
injected sc at the nape of the neck with either morphine or saline; three 
litters received 1.0 mg/ml/kg morphine sulfate and three litters received 
an equivalent volume of 0.9% saline. These pups were separated from their 
mothers for about 15 minutes and were kept in huddles before and after in­
jection. Pups from the remaining three litters were neither weighed nor 
injected but were returned to their mothers immediately after culling. 
Following Day 1 treatment, all animals were left undisturbed until 
weaning. Animals were removed from their mothers and placed with litter-
mates in a stainless steel group-cage on Day 21 and were individually caged 
in standard stainless steel cages on Day 25. In both group and individual 
housing conditions, Teklad pellets and water were continuously available. 
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On Day 26, each animal was injected with either morphine or saline 
and tested for pain responsivity, activity and body temperature. One half 
of the animals from each Day 1 treatment litter were injected sc with 5.0 
mg/ml/kg morphine sulfate and the remaining animals were injected with 0.9% 
saline. Assignment of animals to either morphine or saline treatment was 
random with the stipulation that each group consist of an approximately 
equal number of males and females. Animals were tested for pain respon­
sivity 30 minutes after injection. The animal was placed on the hot plate 
surface (52° C) and latency to perform a paw-lick response to a front or 
hind paw was recorded as paw-lick latency (PLL). If a paw-lick response 
was not observed within 120 sec, the test was terminated and PLL recorded 
as 120 sec. Activity was tested 45 minutes after injection. The animal 
was placed in the activity apparatus for 90 sec and each photobeam inter­
ruption was recorded as an activity count. Body temperature was. recorded 
60, 120, and 180 minutes after injection. The animal was hand-held and the 
thermistor bead inserted 1 cm into the rectum. After approximately 15 sec, 
resistance was recorded to the nearest 0.01 k 0, and k data were later 
transformed to C° data. In all cases, animals were returned to their home 
cages between postinjection tests. 
Injections and postinjection tests on Day 26 (Test Day 1) were repeated 
on Days 27 and 28 (Test Days 2 and 3). On Day 29 (Test Day 4), all animals 
were injected with 5.0 mg/ml/kg morphine and tested for pain responsivity, 
activity and body temperature as described for Test Days 1-3. Summaries of 
the different treatment groups and postinjection tests are provided in Ta­
bles 1 and 2 respectively. 
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Table 1. Summary of treatment groups in Experiment 1. 
Infant Injection Test Day Injection 
Group # Litters Day 1 Sub-group N Days 26-28 Day 29 
A 3 None A^ 11 Morphine Morphine 
4 11 Saline Morphine 
B 3 Saline 12 Morphine Morphine 
^2 12 Saline Morphine 
C 3 Morphine 9 Mo rphine Morphine 
S 9 Saline Morphine 
Table 2. Nummary of postinjection tests on each test day. 
Postinjection 
Interval (min) Test 
30 Pain Responsivity 
45 Activity 
60 Body Temperature 
120 Body Temperature 
180 Body Temperature 
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Data analysis. Potential sex and litter effects on pain responsivity, 
activity and body temperature were considered nuisance variables. Although 
potential sex differences were controlled experimentally by assigning 
approximately one half male and one half female to each treatment group, 
potential litter differences were not controlled. These potential litter 
effects were therefore assessed by separate hierarchial ANOVAs for each 
dependent measure in which animals were nested in litters and litters were 
nested in Day 1 treatment. In these preliminary analyses, data were col­
lapsed across within-group factors. 
Infant and test day treatment differences were analyzed as separate 
split-plot ANOVAs for each dependent measure. Comparisons between infant 
morphine treated and untreated animals were not of interest. Thus, data 
obtained from infant untreated and saline treated animals were analyzed 
separately from those obtained from infant saline treated and morphine 
treated animals . Significant interactions were subsequently analyzed for 
simple main effects. 
Results 
Table 3 summarizes the mortality data for each infant treatment group. 
Although there was no significant difference in number of mortalities be­
tween infant saline treated and untreated animals, morphine treatment 
produced significantly more mortalities than both saline and no treatments 
(x = 4.97; ^  = 1; 2 <.05). All mortalities occurred prior to weaning at 
21 days of age. 
Hierarchal analyses of variance revealed no significant differences 
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Table 3. Number of mortalities from infant untreated, saline treated and 
morphine treated groups in Experiment 1. 
Injection # Alive # Alive 
Group # Litters on Day 1 on Day 1 on Day 26 Mortality 
A 3 None 29 22 24% 
B 3 Saline 27 24 11% 
C 3 Morphine 30 18 40% 
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among litters in either pain responsivity, activity, or body temperature 
on test days 1-3. In these analyses, animals tested following test in­
jections of morphine displayed longer PLLs (F^ = 22,49; df^ = 1, 6; 2 < 
.01), less activity (F = 71.59; d^ =1, 6; 2. .001), and higher body 
temperature = 71.59; ^  = 1, 6; & ^ .001) than animals tested following 
saline. Since no litter effects were obtained on these measures, all sub­
sequent statistical analyses were performed without regard to litter dif­
ferences . 
Pain responsivity. Figure 1 summarizes the pain responsivity data 
obtained from infant untreated (Panel A) and saline treated (Panel B) 
animals following either morphine or saline injections on test days 1-3. 
In these infant treatment groups, morphine on test day 1 produced signi­
ficantly longer PLLs than saline (% = 72.85; ^  = 1, 70; ^ .001). 
There was a significant decline in PLLs across test days 1-3 following 
either morphine (F = 92.33; ^  = 2, 84; 2. ^  .001) or saline (F^ = 7.10; ^  
= 2, 84; 2 ^ .01). On test day 3, there was no significant difference in 
PLLs between morphine and saline injected animals. The magnitude of mor­
phine-induced analgesic effect and rate of tolerance development were not 
influenced by saline injection in infancy, as there were no significant 
differences in PLLs between infant saline treated and untreated animals. 
Figure 2 summarizes the data obtained from these same treatment groups 
when each animal was administered morphine on test day 4. For groups la­
belled Morph this was their fourth test injection of morphine and for 
groups labelled Sal this was their first test injection of morphine. Tol­
erance is evident in that Morph groups displayed significantly shorter PLLs 
Figure 1. Mean paw-lick latencies obtained following either morphine or saline 
on test days 1-3 from animals untreated in infancy (Panel A) and 
animals treated with saline in infancy (Panel B) in Experiment 1. 
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Figure 2. Mean paw-lick latencies obtained following morphine on test day 4 
from animals untreated in infancy (Panel A) and animals treated 
with saline in infancy (Panel B) in Experiment 1. Morph groups 
previously received morphine injections on test days 1-3 and Sal 
groups previously received saline injections on test days 1-3. 
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than Sal groups (F = 18.20; ^  = 1, 42; £ < .001). There was no signif­
icant difference in PLLs between infant untreated (Panel A) and saline 
treated (Panel B) animals. Moreover, regardless of infant treatment, 
animals given morphine for the first time on test day 4 (Fig 2, Sal groups) 
displayed significantly shorter PLLs than animals given morphine for the 
first time on test day 1 (Fig 1, Morphine groups on test day 1; % = 10.44; 
df = 1, 44; 2. <'01). This latter attenuation in PLL was produced by re­
peated hot plate tests independent of morphine and presumably reflects 
behavioral tolerance (e.g., Kayan, Ferguson, and Mitchell, 1973). 
Although there were no significant differences in pain responsivity 
between infant saline treated and untreated animals, there were signifi­
cant differences between infant morphine and saline treated animals. Fig­
ure 3 summarizes the PLL data obtained from infant saline treated (Panel 
A) and morphine treated (Panel B) animals following either morphine or 
saline injections on test days 1-3. In these infant treatment groups, 
morphine on test day 1 produced significantly longer PLLs than saline (2 
= 30.14; ^ f = 1, 63; 2 ^ .001). There was a significant decline in PLLs 
across test days 1-3 following either morphine (^ = 44.49; ^  = 2, 76; 2. 
< .001) or saline (^ = 4.69; df = 2, 76; 2. < .05). On test day 3, there 
was no significant difference in PLLs between morphine and saline injected 
animals. Tolerance was potentiated by morphine treatment in infancy, as 
infant morphine treated animals displayed significantly shorter PLLs on 
test day 1 than infant saline treated animals (£ = 14.16; ^  = 1, 63; 2 < 
•05). This decrease in PLLs produced by infant morphine treatment was 
obtained regardless of whether the injection on test day 1 was morphine 
Figure 3. Mean paw-lick latencies obtained following either morphine or saline 
on test days 1-3 from animals treated with saline in infancy (Panel A) 
and animals treated with morphine in infancy (Panel B) in Experiment 1. 
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or saline. Figure 4 summarizes the data obtained from these same treat­
ment groups when each animal was administered morphine on test day 4. Tol­
erance resulting from morphine injections on test days 1-3 is evident in 
that Morph groups displayed shorter PLLs than Sal groups. This difference 
was significant for infant saline treated animals (Panel A; 2 = 21.42; ^  
= 1, 38; 2. .05) but not for infant morphine treated animals (Panel B) . 
Moreover, tolerance resulting from infant morphine treatment was evidenu 
in that infant morphine treated animals displayed shorter PLLs than infant 
saline treated animals. This difference was significant for Sal groups 
(F = 12.11; jif = 1, 38; _£ < .05) but not for Morph groups. These data 
indicate that infant morphine treatment potentiated the development of 
morphine analgesic tolerance. 
Activity. Figure 5 summarizes the activity data obtained from infant 
untreated (Panel A) and saline treated (Panel B) animals following either 
morphine or saline injections on test days 1-3. In these infant treatment 
groups, morphine on test day 1 produced significantly less activity than 
saline (^ = 34.84; ^  = 1, 45; < .001). There was a significant in­
crease in activity across test days 1-3 following morphine (_F = 7.61; ^  
=2, 68; _£ < .01) and a significant decrease in activity across test days 
1-3 following saline (^ = 5.63; df = 2, 68; 2. < .01). On test day 3, there 
was no significant difference in activity between morphine and saline in­
jected animals. Although the magnitude of morphine-induced hypoactive 
effect and rate of tolerance development were similar in both of these 
infant treatment groups, infant saline treated animals displayed signif­
icantly less activity than infant untreated animals (F^ = 11.77; d^ = 1, 
Figure 5. Mean activity obtained following either morphine or saline on test 
days 1-3 from animals untreated in infancy (Panel A) and animals 
treated with saline in infancy (Panel B) in Experiment 1. 
100 
80 
60 
O 
< 40 
20 
SALINE 
— O»*" * 
MORPHINE 
A 
J 
I 
TEST DAY 
Figure 6. Mean activity obtained following morphine on test day 4 from animals 
untreated in infancy (Panel A) and animals treated with saline in 
infancy (Panel B) in Experiment 1. Morph groups previously received 
morphine injections on test days 1-3 and Sal groups previously re­
ceived saline injections on test days 1-3. 
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34; 2 .01). This depression in activity was evident on each test day 
1-3 regardless of whether morphine or saline was administered. Figure 6 
summarizes the data obtained from these same treatment groups when each 
animal was administered morphine on test day 4. For groups labelled Morph 
this was their fourth test injection of morphine and for groups labelled 
Sal this was their first test injection of morphine. Tolerance is evident 
in that Morph groups displayed significantly more activity than Sal groups 
(F = 8.30; ^  = 1, 34; £ < .01). Moreover, infant saline treated animals 
(Panel B) displayed significantly less activity than infant untreated 
animals (Panel A; ^  = 8.57; ^  = 1, 34; £ < .01). This depression in 
activity occurred in both Morph and Sal groups, indicating that the infant 
injection procedure per se depressed later activity independent of mor­
phine . 
Figure 7 summarizes the activity data obtained from infant saline 
treated (Panel A) and morphine treated (Panel B) animals following either 
morphine or saline injections on test days 1-3. In these infant treatment 
groups, morphine on test day 1 produced significantly less activity than 
saline (% = 40.02; ^  = 1, 63; £ < .001). There was a significant in­
crease in activity across test days 1-3 following morphine (£ = 11.26; 
df = 2, 76; £ < .001). On test day 3, there was no significant difference 
in activity between morphine and saline injected animals. Infant mor­
phine treated animals displayed significantly more activity than infant 
saline treated animals on test day 2 (2 = 14.16; ^  = 1, 63; £ < .05) but 
not on test day 1. These data indicate that while tolerance was poten­
tiated by infant morphine treatment, this potentiation was not evident 
Figure 7. Mean activity obtained following either morphine or saline on test 
days 1-3 from animals treated with saline in infancy (Panel A) and 
animals treated with morphine in infancy (Panel B) in Experiment 1. 
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until the second test injection of morphine. Figure 8 summarizes the data 
from these same treatment groups when each animal was administered mor­
phine on test day 4. Tolerance resulting from morphine injections on 
test days 1-3 is evident in that Morph groups displayed significantly more 
activity than Sal groups (2 = 24.25; ^ f = 1, 38; ^  < .001). However, tol­
erance resulting from infant morphine treatment is not evident, as there 
was no significant difference in activity between infant saline treated 
(Panel A) and morphine treated (Panel B) animals. These data, together 
with those summarized in Figure 7, suggest that more than one test injec­
tion of morphine may be necessary to observe hypoactive tolerance result­
ing from the infant morphine treatment. 
Body temperature. Table 4 summarizes the body temperature data ob­
tained from all treatment groups across all test days and all postinjection 
intervals. In both infant untreated and saline treated animals, morphine on 
test day 1 produced significantly higher body temperatures than saline 60 
min after injection (2 = 123.00; ^  = 1, 70; < .001). On this test day, 
there was a significant decline in body temperature measured 60, 120 and 
180 min after either morphine (2 = 252,58; ^ f = 2, 84; _£ < .001) or saline 
(F = 21.23; ^  = 2, 84; < .001). There was no significant difference in 
body temperature between morphine and saline injected animals 180 min after 
injection. Tolerance to the morphine-induced hyperthermic effect was not 
obtained, as there was no significant decline in body temperature across 
test days 1-3. Independent of morphine, infant saline treated animals 
displayed higher body temperatures than infant untreated animals. This 
difference was significant 60 min after injection on test day 2 (F = 4.13; 
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Table 4. Mean body temperatures obtained from animals untreated, saline 
treated and morphine treated in infancy and tested following 
either morphine or saline injection in Experiment 1. The three 
values for each subgroup on each test day represent mean tem­
peratures recorded 60, 120 and 180 min after injection respec­
tively, On test day 4, all injections were morphine. 
Infant Test Day 
Group Injection Subgroup Injection 
Mean Body Temperature (C°) 
Day 1 Day 2 Day 3 Day 4 
(morphine) 
None 
Saline B, 
Morphine C 
Morphine 37.9 37.7 37.5 37.7 
37.2 37.0 37.1 37.3 
36.3 36.5 36.3 36.2 
Saline 36.6 36.7 :#.8 37.8 
36.4 216.6 36.5 37.5 
36.2 :#.4 36.3 36.3 
Morphine 37.7 3#.3 38.0 38.2 
37.1 37.2 37.1 37.5 
36.2 36.4 36.4 36.6 
Saline 36.5 36.8 37.0 37.9 
36.4 36.4 36.6 37.4 
36.3 36.4 36.2 36.7 
Morphine 37.9 38.2 38.1 38.2 
36.7 37.1 37.2 37.4 
36.6 36.4 36.4 36.5 
Saline 36.8 37.1 37.2 38.1 
36.6 36.7 36.7 37.4 
36.5 36.4 36.3 36.4 
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df = 1, 126; 2. ^ -05) and on test day 3 (P = 4.58; ^  = 1, 126; 2 ^ .05). 
When each animal was administered morphine on test day 4, a similar pat­
tern of results was obtained. Morphine hyperthermic tolerance was not 
evident, as there was no significant temperature difference between 
animals previously given either morphine or saline on test days 1-3. 
Moreover, infant saline treated animals displayed significantly higher 
body temperatures than infant untreated animals 60 min after injection 
(2 = 8.45; ^  = 1, 70; < .01). These data indicate that the infant 
injection procedure per se increased later body temperature independently 
of morphine. 
Although the infant injection procedure influenced later body tem­
perature, infant morphine exposure did not. In both infant saline and 
morphine treated animals, morphine on test day 1 produced significantly 
higher body temperatures than saline 60 min after injection (F^ = 136.49; 
df = 1, 51; 2 .001). There was a significant decline in body temperature 
measured 60, 120 and 180 min after either morphine (2 = 277.53; = 2, 76; 
_£ < .001) or saline (^ = 27.05; ^  = 2, 76; < .001). Tolerance was not 
obtained, as there was no significant decline in body temperatures across 
test days 1-3. When each animal was administered morphine on test day 4, 
there was no significant temperature difference between animals previously 
given either morphine or saline on test days 1-3. Moreover, there was no 
significant difference between infant saline and morphine treated animals, 
indicating that infant morphine exposure did not influence later body tem­
perature. 
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Discussion 
The results of Experiment 1 demonstrate that both morphine and the in­
jection procedure per se, administered one day after birth in rats, can 
produce long-lasting changes in pain responsivity, activity, and body 
temperature. Comparison of data obtained from infant saline treated and 
untreated animals indicated that the injection procedure at one day of age 
decreased activity and increased body temperature measured at 26-29 dayc 
of age. Comparisons between infant morphine treated and saline treated 
animals indicated that morphine exposure at one day of age decreased PLLs 
and increased activity measured at 26-29 days of age. These long-lasting 
changes related to the injection procedure and to morphine exposure were 
observed regardless of whether test injections were morphine or saline. 
These observations demonstrate the importance of using saline injected 
control animals when investigating the influence of acute morphine expo­
sure during early infancy on later morphine effects. 
One purpose of the present experiment was to replicate the observation 
of single-dose hyperanalgesia in one-day-old rats reported by Huidobro and 
Huidobro (1973). These investigators reported that animals given morphine 
one day after birth later displayed greater morphine analgesia (hyper­
analgesia) than animals untreated one day after birth. In contrast, the 
results of the present experiment demonstrated that animals given morphine 
one day after birth later displayed less morphine analgesia (tolerance) 
than animals given saline one day after birth. Although the reasons for 
these conflicting results are unclear, it is unlikely that the difference 
in infant control groups (untreated vs. saline treated) is involved, as 
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there was no difference in pain responsivity between infant untreated and 
saline treated animals in the present experiment (see Figure 1). However, 
differences in test age, pre-injection training on the hot plate, and 
animal strain may be relevant considerations. Huidobro and Huidobro 
tested animals on the hot plate at 16 days of age. In the present exper­
iment, animals were tested at 26-29 days of age. Preliminary data from 
this laboratory indicated that paw-lick responses following saline were 
extremely variable in 16-day-old rats and, with some animals, were not 
observed for up to 180 sec after contact with a 52° C hot plate. Further, 
Huidobro and Huidobro (1973) used albino rats and pretrained them on the 
hot plate prior to assessment of pain responsivity, while the present exper­
iment involved hooded rats and no pretraining. 
Regardless of the source of difference between the present results and 
those reported by Huidobro and Huidobro (1973), hyperanalgesia is not a con­
sistent result of early morphine exposure. The data indicate that a single 
dose of morphine at one day of age produced analgesic tolerance and are 
consistent with reports of single-dose tolerance in adults (Cochin and 
Kornetsky, 1964; Huidobro, Huidobro-Toro, and Way, 1976; Kometsky and 
Bain, 1968). Previous reports have demonstrated long-lasting tolerance 
following morphine exposure in infants (Sonderegger, Bromley, and Zimmermann, 
1977; Sonderegger and Zimmermann, 1976; Sonderegger and Zimmermann, 1978; 
Zimmermann, Branch, Newman Taylor, Young, and Pang, 1974). In these in­
stances, however, morphine exposure was relatively long-term, consisting of 
either pellet implantation or daily injections for one week or longer. The 
present report clearly demonstrates long-lasting single-dose morphine anal­
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gesic tolerance in infants. This tolerance was obtained with a morphine 
dose of 1 mg/kg, which contrasts with the morphine dose of 5-20 mg/kg 
required to produce single-dose tolerance in adults. This difference 
between infants and adults in dosages required to produce single-dose 
tolerance may reflect differences in brain permeability to morphine in 
blood, as the blood-brain barrier to morphine develops between about 16-32 
days of age (Johannesson and Becker, 1973; Johannesson, Steele, and Becker, 
1972; Kupferberg and Way, 1963) and also may involve differences in opiate 
receptor development since there is an approximately 15-fold increase in 
the number of opiate receptors from birth to 60 days of age (Clendeninn, 
Petraitis, and Simon, 1976; Coyle and Pert, 1976). 
Morphine analgesic tolerance obtained in the present experiment may 
involve both pharmacological and behavioral (nonpharmacological) factors 
(Adams, Yeh. Woods, and Mitchell, 1969; Gebhart and Mitchell, 1971; Kayan, 
Ferguson, and Mitchell, 1973). Pharmacological tolerance has been de­
scribed as a diminished analgesic response brought about by morphine 
exposure per se and may reflect alterations in neurotransmitter-receptor 
or immunoreactive mechanisms (Clouet and Iwatsubo, 1975; Cochin, 1970; 
Takemori, 1975). In contrast, behavioral tolerance has been described as 
a diminished analgesic response brought about by experience with either a 
functional or nonfunctional analgesiometric apparatus and may reflect clas­
sical conditioning of an hyperalgesic response (Siegel, 1975), instrumental 
conditioning of a pain indicant response (Gebhart, Sherman, and Mitchell, 
1971), or habituation to novel stimuli associated with the analgesiometric 
apparatus (Bardo and Hughes, 1979). In the present experiment, tolerance 
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evident in infant morphine treated animals may best be described as phar­
macological, because tolerance was obtained on the first test with the not 
plate apparatus. In contrast, tolerance evident in all infant treatment 
groups across repeated morphine injections and tests may be described, at 
least in part, as behavioral. This behavioral contribution to tolerance 
was evident in the diminished analgesic response to morphine resulting 
from prior hot plate tests without morphine (cf. Figure 2, Sal groups and 
Figure 1, morphine groups on test day 1). 
Infant morphine treatment produced tolerance to subsequent morphine-
induced analgesia and potentiated analgesic tolerance development to suc­
cessive morphine injections. The present results demonstrate similar ef­
fects of infant morphine treatment on subsequent morphine-induced hypo-
activity. Tolerance to morphine-induced hypoactivity developed more rapid­
ly across test days 1-3 in infant morphine treated animals than in infant 
saline treated animals (see Figure 7). This tolerance, however, was not 
evident on test day 1 but was evident on test day 2. These data contrast 
with the observation of morphine analgesic tolerance obtained on test day 
1 and demonstrate that the presence or absence of measurable tolerance on 
a single test depends on which particular morphine effect is assessed. 
Unlike analgesic and hypoactive tolerance, infant morphine treatment 
failed to produce tolerance to morphine-induced hyperthermia. Regardless 
of infant treatment, morphine produced a robust hyperthermic effect that 
did not decline across repeated injections and tests. These data are not 
consistent with at least one report of morphine hyperthermic tolerance 
following repeated injections and tests in adult rats (Siegel, 1978). How­
42 
ever, the conditions necessary for obtaining morphine hyperthermic tol­
erance are not clear, as several other reports indicate that morphine-
induced hyperthermia may actually increase following repeated injections 
(Gunne, 1960; Martin, Pryzbylik, and Spector, 1977; Thornhill, Hirst, and 
Gowdey, 1978). Despite this discrepancy in the literature, the present 
failure to obtain hyperthermic tolerance is consistent with the observation 
that, relative to analgesic and hypoactive tolerance, the rate at which 
morphine tolerance develops to hyperthermia is extremely slow (Fernandes, 
Kluwe, and Coper, 1977). 
Finally, acute morphine-induced analgesia has been reported to be 
positively correlated with the number of opiate receptors prior to BBS 
development (Auguy-Valette. Gros, Gouarderes, Gout, and Pontonnier, 1978). 
Morphine-induced analgesic tolerance may also be related to opiate receptor 
development during this same period of infancy. If morphine tolerance is 
directly related to number of opiate receptors prior to BBB development, 
then the degree of tolerance produced by a 1 mg/kg morphine injection one 
day after birth, as obtained in experiment 1, ought to decrease as a func­
tion of increased injection age. Experiment 2 examined this possibility. 
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EXPERIMENT 2 
This experiment was designed to assess the potential influence of 
single-dose morphine treatment at either 1, 5,9, or 13 days of age on 
later morphine-induced analgesia, hypoactivity and hyperthermia. This 
particular age range was chosen because it is characterized by rapid 
opiate receptor development with minimal BBB influence. 
Method 
Animals. Sixteen multiparous female Long-Evans hooded rats (Blue 
Spruce Farms, New York) were mated in this laboratory with male rats of 
the same strain. Mating consisted of randomly housing one female and one 
male together for 10 consecutive days. Following this, females were indi­
vidually caged and maintained as described in Experiment 1. 
Apparatus. Apparatus was that described in Experiment 1. 
Procedure. Females were examined twice daily for parturition, once 
in the morning and once in the afternoon. The day on which a litter was 
first observed was designated as parturition for that litter (Day 0). On 
Day 1, each litter was sexed and culled to 10 pups (5 male and 5 female) 
whenever possible. 
Treatment was generally similar to that described in Experiment 1 ex-r. 
cept that an untreated group was not used and an additional variable, age 
at which infants were initially administered morphine or saline, was inves­
tigated. On Day 1, animals from two randomly chosen litters were injected 
with 1 mg/ml/kg morphine sulfate and animals from two other randomly chosen 
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litters were injected with 0.9% saline. Twelve more litters were similarly 
treated except that treatment occurred on either Day 5, 9, or 13, with four 
litters (2 morphine and 2 saline) randomly treated at each age. Animals 
were weaned and housed as described in Experiment 1. 
On Day 26, one half of the animals from each treatment litter were in­
jected with 5 mg/ml/kg morphine and the other half were injected with sa­
line. Assignment of animals to either the morphine or saline treatment 
group was random with the stipulation that each group consist of an approx­
imately equal number of males and females. Each animal was subsequently 
tested for pain responsivity, activity, and body temperature after either 
morphine or saline injection as described in Experiment 1. These injections 
and tests were repeated on Days 27 and 28. On Day 29, all animals were in­
jected with morphine and tested. The treatment groups are summarized in 
Table 5. 
Data analysis. Statistical analyses of pain responsivity, activity 
and body temperature data generally paralleled those described in Experiment 
1, except that day of infant morphine or saline treatment was included as an 
additional between-groups factor in the split-plot ANOVAs. Trend analyses 
were also used to assess differences between the ages at which morphine or 
saline treatments were administered. 
Results 
Table 6 summarizes the mortality data for each infant treatment group. 
There were no significant differences in number of mortalities between in­
fant treatment groups. Although animals given saline at 9 days of age tend? 
45 
Table 5. Summary of treatment groups in Experiment 2, 
Infant Treatment Test Day Injection 
Sub-
Group # Litters Age (days) Injection Group N Days 26-28 Day 29 
A 2 1 Morphine 4 10 Morphine 
Morphine 
10 Saline Morphine 
B 2 1 Saline 
"l 10 
Morphine Morphine 
9 Saline Morphine 
C 2 5 Morphine 
^1 
11 Morphine Morphine 
^2 
9 Saline Morphine 
D 2 5 Saline 9 Morphine Morphine 
^2 
8 Saline Morphine 
E 2 9 Morphine 9 Morphine Morphine 
^2 
8 Saline Morphine 
F 2 9 Saline 
^1 
7 Morphine Morphine 
^2 6 Saline Morphine 
G 2 13 Morphine 
^1 10 
Morphine Morphine 
S 8 Saline Morphine 
H 2 13 Saline H 
1 
10 Morphine Morphine 
«9 9 Saline Morphine 
Table 6. Mortality of infant treatment groups in Experiment 2. 
# Alive Infant Treatment # Alive Mortality 
// Alive on Following 
Group # Litters on Day 1 Age Injection Treatment Day on Day 26 Treatment 
A 2 20 1 Morphine 20 20 0 % 
B 2 20 1 Saline 20 19 5 % 
C 2 20 5 Morphine 20 20 0 % 
D 2 18 5 Saline 18 17 6 % 
E 2 18 9 Morphine 17 17 0 % 
F 2 20 9 Saline 16 13 19 % 
G 2 19 13 Morphine 18 18 0 % 
H 2 19 13 Saline 19 19 0 % 
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ed to displayed the highest mortality (19%), this tendency did not appear 
to reflect a treatment effect. In this infant treatment group, four an­
imals died before and three animals died after saline injection at 9 days 
of age. 
fain responsivity. Figure 9 summarizes the pain responsivity data ob­
tained from each infant treatment group following either morphine or saline 
on test days 1-4. Treatment groups are abbreviated as M-M, M-S, S-M, and 
S-S, where the first letter refers to treatment in infancy (M = morphine, 
S = saline) and the second letter (M or S) refers to injections on test 
days 1-3. Both infant treatment groups displayed morphine-induced anal­
gesia on test Day 1. Regardless of infant treatment, morphine on this 
test day produced significantly longer PLLs than saline (F = 87.45; ^  = 
1, 212; 2. ^ .001). There was a significant decline in PLLs across test 
days 1-3 following either morphine (2 = 153.43; ^  = 2, 254; 2. .001) or 
saline (F^ = 14.35; ^  = 2, 254; 2 ^ .001). On test day 3, there was no 
significant difference in PLLs between morphine and saline injected ani­
mals. On test day 4, when each animal received morphine, tolerance is 
evident in animals given morphine on test days 1-3, as they displayed 
significantly shorter PLLs than animals given saline on test days 1-3 
(F = 56.06; df = 1, 127; ^  < .001). 
Although test injections of morphine produced an initial analgesic 
effect and subsequent tolerance in both infant treatment groups, the mag­
nitude of these effects was influenced by infant treatment. On test day 
1, animals treated at one day of age with morphine displayed significantly 
shorter PLLs than animals treated at one day of age with saline (F = 4.42; 
Figure 9. Mean paw-lick latencies obtained following morphine or saline 
on test days 1-4 from animals treated with either morphine or 
saline at either 1, 5, 9, or 13 days of age in Experiment 2. 
M-M groups received morphine in infancy and morphine on test 
days 1-3; S-M groups received saline in infancy and morphine 
on test days 1-3; M-S groups received morphine in infancy and 
saline on test days 1-3; and S-S groups received saline in 
infancy and saline on test days 1-3. On test day 4, all injec­
tions were morphine. 
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df = 1, 212; 2, < .05). This effect was evident in animals tested following 
morphine (cf M-M and S-M groups) but not following saline (cf M-S and S-S 
groups) . These data demonstrate that morphine treatment at one day of age 
attenuated later morphine-induced analgesia. This effect on test day Iwas 
not obtained with morphine treatment at either 5,9, or 13 days of age 
however, as there was no significant difference in PLLs between animals 
treated at these ages with either morphine (M-M and M-S groups) or saline 
(S-M and S-S groups). Trend analyses of test day 1 data revealed that in­
fant saline treatment produced a significant linear decrease in PLLs as 
a function of increased treatment age (^  = 7.91; ^  = 1, 212; 2_ < .05). 
This effect demonstrates that the infant injection procedure influenced 
later pain responsivity. There was also a significant quadratic trend 
in PLLs as a function of infant morphine treatment age (|^  = 12.55; df = 1, 
212; 2. < .05). On test day 4, there was a significant interaction effect 
(2 = 5.37; ^  = 3, 127; ^  < .01) involving PLLs of animals treated with 
either morphine or saline at either 9 or 13 days of age and given saline 
of test days 1-3. The basis for interpreting this effect is not readily 
apparent. 
Activity. Figure 10 summarizes the activity data obtained from each 
infant treatment group following either morphine or saline on test days 
1-4. Animals given morphine on test day 1 displayed less activity than 
animals given saline. This effect, however, was statistically significant 
only for groups treated with saline at 1 or 5 days of age, and for groups 
treated with morphine at 5 or 13 days of age (2 - 6.10; ^  = 1, 212; 2 < 
.05 in each case). Morphine on test day 2 produced less activity than 
Figure 10. Mean activity obtained following morphine or saline on test 
days 1-4 from animals treated with either morphine or saline 
at either 1, 5, 9, or 13 days of age in Experiment 2. M-M 
groups received morphine in infancy and morphine on test days 
1-3; S-M groups received saline in infancy and morphine on 
test days 1-3; M-S groups received morphine in infancy and 
saline on test days 1-3; and S-S groups received saline in 
infancy and saline on test days 1-3. On test day 4, all 
injections were morphine. 
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saline in animals treated at one day of age with saline (_F = 13.17; ^  = 
1, 212; 2. < .001). On test day 3, morphine produced significantly greater 
activity than saline in animals treated with saline at 13 days of age and 
in animals treated with morphine at 9 or 13 days of age (J - 4.48; = 
1, 212; £ < .05 in each case). Tolerance to morphine-induced hypoactivity 
was evident when all animals received morphine on test day 4, as animals 
given morphine on test days 1-3 displayed greater activity th.an animals 
given saline on test days l'-3 (P = 73.30; ^  = 1, 127; 2 < .0011, 
Although test injections of morphine produced an initial hypoactive 
effect to which tolerance developed, the magnitude of effect was influenced 
by infant treatment. Animals treated at one day of age with morphine 
displayed significantly more activity than animals treated at one day of 
age with saline when morphine was given on test day 1 (2 = 23.80; ^  = 1, 
212; 2 < .001), but not when saline was given on test day 1. These data 
demonstrate that morphine treatment at one day of age attenuated later 
morphine-induced hypoactivity. This effect on test day 1 was not obtained 
with morphine treatment at either 5,9, or 13 days of age however, as there 
was no significant difference in activity between animals treated at these 
ages with either morphine (M-M and M-S groups) or saline (S-M and S-S groups). 
Trend analyses of test day 1 data as a function of increased treatment age 
revealed a significant linear trend in M-M animals (F = 4.81; ^  = 1, 212; 
2 < .05) and S-M animals (2 = 10.93; ^  = 1, 212; 2 ^ .01), and a significant 
quadratic trend in M-S animals (F = 7.74; = 1, 212; 2 .01). These data 
indicate that the age at which either morphine or saline was given in infancy 
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influenced later activity. On test day 4, there were no significant dif­
ferences in activity between animals treated at either 1, 5, 9, or 13 days 
of age with either morphine or saline. 
Body temperature. Body temperatures of several animals treated at 
9 days of age were not recorded due to an apparatus problem. To avoid ex­
tremely unequal cell sizes, ANOVA was performed only on body temperatures 
from animals treated at 1, 5, or 13 days of age. These data are sum­
marized in Table 7. Morphine on test day 1 produced significantly higher 
body temperatures than saline 60 min after injection (% = 171.40; ^  = 1, 
168; 2 .001) and 120 min after injection (% = 47.45; ^  = 1, 168; 2 < 
.001), but not 180 min after injection. There was a significant decline 
in body temperatures measured 60, 120, and 180 min after either morphine 
(F = 555.72; df = 2, 202; £ < .001) or saline (F = 56.88; df = 2, 202; £ 
< .001). There was no significant change in morphine-induced hyperthermia 
across test days 1-3. On test day 4, when all injections were morphine, 
there was no significant difference in body temperature between animals 
given morphine on test days 1-3 and animals given saline on test days 1-3. 
These data indicate that tolerance to morphine-induced hyperthermia did 
not develop. 
Infant morphine treatment also failed to produce tolerance to morphine-
induced hyperthermia. Animals treated at either 1, 5, or 13 days of age 
with morphine displayed significantly higher body temperatures than animals 
treated at either 1, 5, or 13 days of age with saline = 18.35; df = 1, 
101; 2. < .001). This effect was obtained on test days 1-3 following either 
morphine or saline, but not at each postinjection interval. On test day 
Table 7. Mean body temperatures obtained from animals morphine or saline 
treated at 1, 5, or 13 days old and tested following either 
morphine or saline injection in Experiment 2. The three values 
for each subgroup on each test day represent mean temperatures 
recorded 60, 120 and 180 min after injection respectively. On 
test day 4, all Injections were morphine. 
Infant Treatment Test Day 
Group Age (days) Injection Subgroup Injection 
Mean Body Temperature (C°) 
Day 1 Day 2 Day 3 Day 4 
(morphine) 
Morphine 37.6 37.6 37.7 37.9 
37.0 36.8 37.1 37.2 
36.2 36.3 36.5 36.4 
Saline 36.8 36.9 37.0 37.8 
36.6 36.7 36.9 37.1 
36.5 36.5 36.8 36.2 
Morhpine 37.2 37.6 37.6 37.7 
36.8 37.1 37.0 37.1 
36.2 35.9 35.8 36.0 
Saline 36.5 36.6 36.7 37.7 
36.4 36.4 36.4 37.2 
36.3 36.3 36.3 36.1 
Morphine 37.8 37.9 37.9 37.8 
37.1 37.0 36.7 36.8 
36.4 36.0 36.1 36.0 
Saline 36.9 37.2 37.2 37.7 
36.4 36.6 36.5 36.8 
36.2 36.0 36.3 36.0 
Morphine 
Saline 
Morphine 
Table 7 (Continued) 
Infant Treatment Test Day Mean Body Temperature (C°) 
Group Age (days) Inj ect ion Subgroup Injection Day 1 Day 2 Day 3 Day 4 
(morphine) 
D 5 Saline Morphine 37.8 
37.1 
36.2 
37.5 
36.9 
35.8 
37.3 
36.9 
36.1 
37.4 
36.9 
36.0 
2^ Saline 36.6 36.4 
36.1 
36.6 
36.2 
36.0 
36.7 
36.4 
36.1 
37.5 
36.9 
36.0 
G 13 Morphine 1^ Morphine 37.9 36.9 
36.0 
37.9 
37.1 
36.0 
37.6 
37.2 
36.6 
37.6 
37.1 
36.4 
«2 Saline 36.8 
36.4 
36.2 
37.1 
36.9 
36.5 
37.3 
36.9 
36.8 
37.6 
37.4 
36.5 
H 13 Saline »1 Morphine 37.7 
36.9 
36.1 
37.5 
36.9 
36.1 
37.7 
36.9 
36.4 
37.5 
37.0 
36.0 
«2 Saline 3 6 . 2  
36.1 
35.9 
3 6 . 6  
36.6 
36.0 
3 6 . 9  
36.7 
36.6 
37.4 
37.2 
36.1 
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4, infant morphine treated animals displayed significantly higher body 
temperatures than infant saline treated animals 60 min after injection 
(2 = 6.82; ^  = 1, 168; £ < .05) and 180 min after injection (F = 7.75; 
df = 1, 168; 2 < .05). These data indicate that morphine treatment at 
either 1, 5, or 13 days of age increased later body temperature. 
Discussion 
The results of Experiment 2 demonstrate that a single morphine dose 
administered at different periods of infancy can differentially influence 
later morphine-induced analgesic and hypoactive effects. Morphine exposure 
at one day of age decreased PLLs and increased activity measured after 
morphine injection at 26 days of age. In contrast, morphine exposure at 
either 5, 9, or 13 days of age did not influence PLLs or activity measured 
after morphine injection at 26 days of age. These results indicate that 
the efficacy of 1.0 mg/kg morphine in producing long-lasting single-dose 
tolerance in infants declines soon after one day of age. 
Although early morphine treatment produced tolerance to later morphine 
induced analgesic and hypoactive effects, this treatment did not produce 
tolerance to later morphine-induced hyperthermia. Single-dose morphine 
administered at either 1, 5, or 13 days of age increased rather than de­
creased body temperatures measured at 26-29 days of age. Moreover, this 
effect was obtained regardless of whether body temperatures were measured 
after morphine or saline injections. These results indicate that morphine 
treatment in infancy can produce long-lasting alterations in body temper­
ature regulation. 
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Infant morphine treatment produced long-lasting age-dependent changes 
in pain responsivity, activity, and body temperature. Long-lasting age- de­
pendent changes in pain responsivity and activity were also produced by 
saline treatment. Animals given saline early in infancy displayed greater 
morphine-induced analgesic and hypoactive effects than animals given saline 
later in infancy (cf. S-M and S-S groups on test day 1 in Figures 9 and 10). 
Thus, the injection procedure per se administered at different infancy 
periods influenced later morphine effects. However, these age-related 
effects of infant saline treatment were not observed for morphine-induced 
hyperthermia. 
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GENERAL DISCUSSION 
A single injection of 1 mg/kg morphine in one-day-old rats produced 
long-lasting tolerance to subsequent morphine-induced analgesic and hypo-
active effects but not to hyperthermic effects. In Experiment 1, animals 
given morphine at one day of age displayed shorter PLLs and greater activ­
ity at 26-28 days of age than animals given saline at one day of age. 
These effects were obtained regardless of whether animals were tested 
following morphine or saline. The PLL results contrast with the observa­
tion by Huidobrc and Huidobro (1973) that morphine treatment at one day 
of age produced relatively long PLLs indicative of morphine-induced hyper-
analgesia. However, the present results are consistent with observations 
of single-dose tolerance in adults (Cochin and Kometsky, 1964; Kornetsky 
and Bain, 1968) and with observations of tolerance following multiple doses 
or pellet implantation in infants CSonderegger, Bromley, and Zimmermann, 
1977; Sonderegger and Zimmermann, 1976; Sonderegger and Zimmermann, 1978; 
Zimmermann, Branch, Newman Taylor, Young, and Pang, 1974). Furthermore, 
these results are also consistent with the observation that, relative to 
analgesic and hypoactive effects, the development of tolerance to hyper­
thermia is extremely slow (Femandes, Kluwe, and Coper, 1977). 
Single-dose tolerance to 1 mg/kg morphine in infants was age-depen-
dent. In Experiment 2, morphine treatment at 1 but not at 5, 9, or 13 days 
of age attenuated morphine-induced analgesic and hypoactive effects as as—, 
sessed at 26-28 days of age. This age-dependent change in susceptibility to 
single-dose tolerance with 1 mg/kg morphine may reflect either a difference 
in the interval between infant morphine treatment and tolerance assessment. 
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a change in BBB development, or a change in opiate receptor development. 
Age-dependent changes in susceptibility to single-dose tolerance may 
reflect a change in the interval between infant morphine treatment and tol­
erance assessment. Tolerance assessment was initiated at 26 days of age 
regardless of when morphine was administered in infancy. Thus, animals 
treated at 1 day of age had a longer interval between morphine treatment 
and tolerance assessment than animals treated at either 5, 9, or 13 days 
of age; i.e., animals treated at either 1, 5, 9, or 13 days of age had 
treatment-tolerance assessment intervals of either 25, 21, 17, or 13 days 
respectively. Tolerance obtained following morphine at 1 but not at 5, 9, 
or 13 days of age might therefore suggest that a 25-day "incubation" period 
is necessary for tolerance to be manifest. According to this interpreta­
tion, morphine administration at either 1, 5, 9, or 13 days of age would 
be expected to produce similar tolerance if assessed at either 26, 30, 34, 
or 38 days of age respectively. This possibility however, is not consis­
tent with reports demonstrating that tolerance decreases when the inter­
val between initial morphine treatment and tolerance assessment increases 
beyond about three days CCochin and Rometsky, 1964; Huidobro, Huidobro-
Toro, and Way, 1976). This evidence suggests that animals treated late 
in infancy should have displayed greater tolerance than animals treated 
early in infancy. Since this effect was clearly not obtained, it is un­
likely that the age-dependent change in susceptibility to tolerance re­
ported here reflects a difference in treatment-tolerance assessment inter­
vals . 
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Age-dependent changes in susceptibility to morphine tolerance may 
reflect a change in BBB development. As previously described, the BBB 
to morphine is virtually nonexistent up to about 15 days of age, but 
rapidly develops from this time and becomes adult-like by about 32 days 
of age (Johannesson and Becker, 1973; Johannesson, Steele, and Becker, 
1972; Kupferberg and Way, 1963). During this period of BBB development, 
there is a concomitant decrease in morphine-induced analgesic effect 
CHuidobro and Huidobro, 1973), These observations indicate that the 
magnitude of morphine-induced analgesic and perhaps hypoactive effects 
are potentially related to BBB maturation. If this is the case, then 
the attenuation in morphine-induced analgesic and hypoactive effects 
produced by morphine treatment at 1 but not at 5, 9, or 13 days of age 
in the present experiments may reflect a potentiation in BBB maturation 
induced by morphine treatment at 1 but not at 5, 9, or 13 days of age. 
This possibility could be investigated by assaying morphine levels in 
brain and blood after morphine injection at 26 days of age in animals 
previously treated with morphine at different periods of infancy. 
Age-dependent changes in susceptibility to morphine tolerance may 
reflect a change in opiate receptor development. As previously described, 
opiate receptors are first evident two weeks into gestation and progres­
sively increase in number up to adulthood (Clendeninn, Petraitis, and 
Simon, 1976; Coyle and Pert, 1976). These receptors appear to be in­
volved in morphine-induced analgesia, as morphine-induced analgesia is 
antagonized by naloxone, an opiate antagonist which has greater affinity 
for the opiate receptor than morphine (Terenius, 1974). Moreover, mor­
phine produces analgesia when microinjected into high density but not 
low density opiate receptor sites (Mayer and Murphin, 1976; Yaksh, Yeung, 
and Rudy, 1976), and finally the analgesic efficacy of morphine is direct 
ly correlated with the normal ontogenetic increase in number of opiate 
receptors from birth to about 15 days of age in rats (Auguy-Valette, Gros 
Gouarderes, Gout, and Pontonnier, 1978), Opiate receptors may also be in 
volved in morphine-induced hypoactivity, as morphine-induced hypoactivity 
like analgesia, is antagonized by naloxone CBhargava, 1978). These ob­
servations suggest that the magnitude of morphine-induced analgesic and 
hypoactive effects may be related to the number of opiate receptors in 
brain. If this is the case, then the attenuation in morphine-induced 
analgesic and hypoactive effects produced by morphine treatment at 1 but 
not at 5, 9, or 13 days of age in the present experiments may reflect an 
attenuation in opiate receptor development induced by morphine treatment 
at 1 but not at 5, 9, or 13 days of age. This possibility is consistent 
with evidence indicating that the number of opiate receptors decreases 
following morphine treatment. Although this effect has only been observed 
in adult brain slices (Davis, Akera, and Brody, 1975), there is some ev­
idence that infant treatment can alter opiate receptor development. In 
infants, the number of opiate receptors has been reported to increase fol­
lowing naloxone (Diaz, Paul, Frenk, and Bailey, 1978) or stress (Torda, 
1977). One report, however, has failed to observe any alteration in the 
number of opiate receptors in infants following morphine (Coyle and Pert, 
1976) . Clearly, further research is necessary to determine whether the 
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age-dependent change in susceptibility to tolerance reported here reflects 
a change in opiate receptor development. 
Changes in opiate receptor or BBB development may underly age-depen­
dent changes in morphine tolerance. The present experiments demonstrate 
that these possibilities may be assessed following acute low'-dose morphine 
treatment. Previous reports of long-lasting morphine tolerance in infants 
have administered morphine for one week or Ipnger (Sonderegger, Erpmley, and 
Zimmermann, 1977; Sonderegger and Zimmermann, 1976; Sonderegger and 
Zimmermann, 1978; Zimmermann, Branch., Newman Taylor, Young, and Pang, 1974). 
Such long-term treatment does not allow for evaluation of age^ dependent 
changes in susceptibility to tolerance within a short period of infancy 
such as from 1 to 13 days of age. Moreover, such long-term treatment in 
infancy increases mortality CZinnaennann, Sonderegger and Bromley, 1977). 
In the present experiments, mortality following morphine treatment was 
minimized by acute injection and in fact was not observed following acute 
morphine at either 1, 5, 9, or 13 days of age in Experiment 2. 
Early morphine injection clearly influenced subsequent response mea^  
sures. The present results also demonstrate that early saline injection 
can produce robust long-lasting changes in pain responsivity, activity, 
and body temperature. In Experiment 1, animals treated with saline at 
one day of age displayed less activity and higher body temperatures than 
animals untreated at one day of age. These effects were obtained at 26-28 
days of age regardless of whether animals were tested following morphine 
or saline. In Experiment 2, animals treated early in infancy with saline 
displayed longer PLLs and less activity than animals treated late in in­
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fancy with saline. These effects were obtained at 26-28 days of age when 
animals were tested following morphine. Some evidence suggests that these 
effects may be stress-related. 
Stressful stimulation during infancy produces a variety of long-last­
ing physiological and behavioral changes in rats CDaly, 1973; Denenberg 
and Zarrow, 1971; Levine, 1969; Russell, 1971). These changes reflect 
direct effects on the infant, as well as indirect effects induced by al­
terations in maternal care (Bamett and Bum, 1967; Bell, Nitschke, Bell, 
and Zachman, 1974; Smotherman, Wiener, Mendoza, and Levine, 1977). Stress 
effects in infants have typically been produced by administering intense 
and chronic sensory stimulation over a long period of infancy; e.g,, inter­
mittent shock applied throughout preweaning development. In the present 
experiments however, changes in pain responsivity, activity, and body 
temperature were produced by administering relatively moderate and acute 
sensory stimulation over a brief period of infancy; i.e., saline injection 
applied at either 1, 5, 9, or 13 days of age. The injection procedure in­
volved a 15-minute period of separation from the lactating mother, during 
which time infants were handled and injected with saline. Changes in pain 
responsivity, activity, and body temperature produced by the infant saline 
treatment may therefore reflect stress induced by separation from the moth­
er, handling, and/or the injection procedure. Regardless of these factors 
played a role in the long-lasting changes produced by infant saline treat­
ment reported here, the present observations illustrate the difference be­
tween saline-injected and untreated control groups for assessing long-last­
ing psychopharmacological consequences of infant drug treatment. 
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Finally, saline administration at 26-28 days of age also may have in­
fluenced pain responsivity, activity, and body temperature independent of 
morphine. This possibility was not directly assessed in the present exper­
iments, as no control group was uninjected at 26-28 days of age. However, 
it has previously been shown that saline injection produces a transient 
increase in body temperature CGunne, 1960), suggesting that it may be 
stressful. In the present experiments, body temperatures were higher 60 
minutes after saline injection than 180 minutes after injection. Exposure 
to the hot plate may have contributed to this temperature increase, as 
hot plate tests preceded body temperature measurements and hot plate ex^  
posure is known to be stressful CTorda, 1977), Acute stress produces a 
transient elevation in endogenous morphine-like neuropeptides in brain 
CGuillemin, Vargo, Bossier, Minick, Ling, Rivier, Vale, and Bloom, 1977; 
Madden, Akil, Patrick, and Barchas, 1977) and produces various effects 
which are functionally similar to those produced by morphine, including 
analgesia (Akil, Madden, Patrick, and Barchas, 1976; Bodnar, Kelly, 
Spiaggia, and Glusman, 1978), hypoactivity (Gray, Solomon, Dunphy, Carr, 
and Hession, 1976; Pinel and Mucha, 1973) and hyperthermia (Delini-Stula, 
1970) . These observations indicate that stressful stimulation is an im­
portant factor to consider when assessing morphine effects across the life­
span. 
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